Saturday, August 15

Browsing: GEPNET

Survivors

177Lu-Dotatate Combo Shows Consistent Efficacy Across GEP-NET Subgroups

By NewsCancerAugust 14, 20260

First-line lutetium Lu 177 dotatate (177Lu-dotatate; Lutathera) plus octreotide (Sandostatin) long-acting repeatable (LAR) demonstrated consistent efficacy regardless of tumor grade…

Diagnosis

Determining the Role of Age-Related Signals in GEP-NET Development

By NewsCancerFebruary 20, 20260

In the evolving landscape of oncology, duodenal gastrinomas present a unique biological puzzle where aging, inflammation, and cellular exhaustion converge.…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways

Induced proximity-based therapeutics for advanced prostate cancer

An EZH2–SREBP2 axis promotes cholesterol biosynthesis and represents a noncanonical vulnerability in tumorigenesis

Browsing: GEPNET

177Lu-Dotatate Combo Shows Consistent Efficacy Across GEP-NET Subgroups

Determining the Role of Age-Related Signals in GEP-NET Development

Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways

Induced proximity-based therapeutics for advanced prostate cancer

An EZH2–SREBP2 axis promotes cholesterol biosynthesis and represents a noncanonical vulnerability in tumorigenesis

THBS1+ macrophages drive an immunosuppressive tumor microenvironment and promote progression in early-onset gastric cancer

Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways

Induced proximity-based therapeutics for advanced prostate cancer

An EZH2–SREBP2 axis promotes cholesterol biosynthesis and represents a noncanonical vulnerability in tumorigenesis

THBS1+ macrophages drive an immunosuppressive tumor microenvironment and promote progression in early-onset gastric cancer

Latest Post

Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways

Induced proximity-based therapeutics for advanced prostate cancer

An EZH2–SREBP2 axis promotes cholesterol biosynthesis and represents a noncanonical vulnerability in tumorigenesis

Subscribe to Updates

What's Hot

Browsing: GEPNET